Ahmet Yilmaz Coban Selected Research

Ahmet Yilmaz Coban Research Topics

10	Tuberculosis (Tuberculoses) 01/2021 - 07/2008
4	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 11/2017 - 05/2011
3	Infections 09/2014 - 01/2009
2	Sepsis (Septicemia) 03/2010 - 07/2005
1	Extensively Drug-Resistant Tuberculosis 02/2014
1	Bacterial Infections (Bacterial Infection) 10/2012
1	Mycoses (Diseases, Fungus) 03/2010
1	Cystic Fibrosis (Mucoviscidosis) 10/2009
1	Brucellosis (Malta Fever) 01/2009
1	Tympanosclerosis 12/2008
1	Communicable Diseases (Infectious Diseases) 07/2005
1	Cross Infection (Nosocomial Infection) 07/2005
1	Pulmonary Tuberculosis 01/2005
1	Lung Neoplasms (Lung Cancer) 03/2004

3	Ethambutol (Myambutol)FDA LinkGeneric 01/2021 - 01/2013
3	Streptomycin (Streptomycin Sulfate)FDA Link 01/2021 - 01/2013
3	AgarIBA 01/2021 - 07/2008
3	Rifampin (Rifampicin)FDA LinkGeneric 01/2021 - 01/2013
3	Isoniazid (Ftivazide)FDA LinkGeneric 01/2021 - 05/2011
3	Gentian Violet (Violet, Crystal)FDA Link 05/2019 - 08/2015
3	Pharmaceutical PreparationsIBA 10/2018 - 04/2009
3	Nitrate ReductaseIBA 08/2015 - 05/2011
3	Anti-Bacterial Agents (Antibiotics)IBA 10/2012 - 01/2009
2	malachite greenIBA 08/2015 - 07/2008
1	Pyrazinamide FDA LinkGeneric 07/2020
1	beta Lactam AntibioticsIBA 01/2020
1	resazurinIBA 08/2015
1	ProcalcitoninIBA 03/2010
1	NeopterinIBA 03/2010
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2008
1	CytokinesIBA 12/2008
1	Vancomycin FDA LinkGeneric 07/2005
1	Phenol (Carbolic Acid)FDA Link 01/2005
1	Ammonium SulfateIBA 01/2005
1	HLA-B51 AntigenIBA 03/2004
1	AntigensIBA 03/2004
1	HLA Antigens (Human Leukocyte Antigens)IBA 03/2004

1	Therapeutics 09/2014